Moldtek Technologies Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- April 27, 2026
- Posted by: Kashish Aggarwal
- Category: News
Moldtek Technologies (MOLDTECH) Q4 results for FY26 are expected in May 2026. With Q3 FY26 revenue of Rs 85 Cr and PAT of Rs 22 Cr as the base, the street is watching closely for margin trajectory and management guidance on FY27 demand.
Get Free SEBI-Registered Research on Moldtek Technologies — Click Here
Moldtek Technologies Q4 FY26 Earnings Preview — What to Expect
Indian IT companies navigate a cautious macro environment in Q4 FY26, with large deal wins providing revenue visibility, AI-led services gaining commercial traction and margin improvement from operational efficiency partially offsetting slow discretionary spending recovery.
Moldtek Technologies Q4 Results 2026 — Date and Key Estimates
| Parameter | Q3 FY26 Actual | Q4 FY26 Estimate | YoY Growth |
|---|---|---|---|
| Revenue (Rs Cr) | 85 | 92 | +8% |
| PAT (Rs Cr) | 22 | 25 | +14% |
| EBITDA Margin | — | 27.2% | Improvement expected |
| Results Date | — | May 2026 | — |
| Dividend History | Rs 8.00 per share | ||
| Dividend Expectation | Rs 10.00 final dividend expected | ||
Estimates based on analyst consensus as of April 2026. Actual results may vary. Verify before investing.
Track Moldtek Technologies live price, FII/DII activity and fundamentals on Univest Screener
5 Reasons Moldtek Technologies Q4 Results Could Beat Estimates
Deal Win Momentum
Large-deal TCV is building across cloud migration, ERP modernisation, AI-augmented services and managed infrastructure. Multi-year contracts provide strong near-term revenue visibility and reduce quarterly earnings variability significantly.
Generative AI Revenue Contribution
AI-led project wins are now contributing meaningfully to reported revenue. Productivity tools, AI platform services and enterprise automation use cases are gaining rapid corporate adoption across verticals.
Cost Structure Improvement
Fresher hiring, utilisation optimisation and subcontracting rationalisation are supporting EBIT margin recovery even in a slow-revenue environment, with companies guiding for 50 to 100 basis points of improvement.
BFSI and Healthcare Vertical Resilience
Banking, financial services and healthcare tech spending has remained relatively resilient, providing revenue cushion against weakness in discretionary retail and hi-tech verticals.
Currency Tailwind on USD Revenue
A modestly weaker rupee against USD provides a positive tailwind for rupee-denominated revenues and margins on dollarised contracts, offering a natural hedge for the business.
5 Key Risks to Watch in Moldtek Technologies Q4 Results
Global Macro Uncertainty
US and EU growth concerns, geopolitical conflicts and interest rate volatility may delay enterprise technology spending decisions further, prolonging the slow discretionary recovery.
Discretionary Spend Weakness
Retail, hi-tech and telecom vertical clients remain cautious on new discretionary project investments, limiting new project ramp-ups.
AI Talent Cost Inflation
Rising compensation demands for AI, ML and cloud-specialised talent compresses margins in the fastest-growing service lines.
GCC Competition Risk
Growth of Global Capability Centres in India is shifting some IT services work in-house for large global enterprises, gradually reducing the addressable outsourcing market.
BFSI Client Concentration Risk
Overweight exposure to banking clients creates sensitivity to financial sector regulatory changes and credit cycle disruptions that can cause sudden budget freezes.
Analyst Ratings and Target Price for Moldtek Technologies
| Brokerage | Rating | Key Thesis |
|---|---|---|
| CLSA | Outperform | AI deal wins to drive revenue re-acceleration |
| JPMorgan | Neutral | Near-term macro headwinds offset by deal strength |
| Kotak Institutional | Buy | Margin improvement and AI revenue upside ahead |
Analyst ratings are for informational purposes only and subject to change. Not investment advice.
Q4 Results 2026 Calendar — Key Dates to Track
| Company | Expected Results Date |
|---|---|
| Moldtek Technologies | May 2026 |
| TCS | April 2026 |
| Infosys | April 2026 |
Stay updated on all Q4 FY26 earnings at Univest Blogs. For TCS results see TCS Q4 Results 2026 and for Infosys see Infosys Q4 Results 2026.
How to Invest in Moldtek Technologies Based on Q4 Results
Before investing in Moldtek Technologies based on Q4 results, consider the following approach: review the actual revenue and PAT versus analyst estimates, listen to the management earnings call for FY27 guidance, assess whether the EBITDA margin trajectory is improving or deteriorating, and check FII/DII activity patterns post-results. A beat on estimates with positive guidance is typically a bullish signal; a miss with downgraded guidance may indicate further correction risk.
Frequently Asked Questions — Moldtek Technologies Q4 Results 2026
Q: When will Moldtek Technologies announce Q4 FY26 results?
Moldtek Technologies (MOLDTECH) is expected to announce Q4 FY26 results in May 2026. The exact board meeting date will be communicated via BSE/NSE exchange filing. Track the date on Univest Screener.
Q: What is the revenue estimate for Moldtek Technologies Q4 FY26?
Analyst consensus estimates Moldtek Technologies Q4 FY26 revenue at approximately Rs 92 Cr, representing approximately 8% year-on-year growth. The actual number will depend on sector demand trends and execution in the quarter.
Q: What PAT is expected for Moldtek Technologies in Q4 FY26?
Estimated PAT for Moldtek Technologies Q4 FY26 is approximately Rs 25 Cr, up approximately 14% year-on-year. Margin expansion from operating leverage and input cost moderation are the primary drivers of profit growth expectations.
Q: Will Moldtek Technologies declare a dividend in Q4 FY26?
Historical dividend pattern for Moldtek Technologies: Rs 8.00 per share. For Q4 FY26, Rs 10.00 final dividend expected. Dividend declarations are subject to board approval at the time of results.
Q: What is the current share price and market cap of Moldtek Technologies?
Moldtek Technologies (MOLDTECH) is currently trading at approximately Rs 680 with a market capitalisation of Rs 1,050 Cr. Track live price, volume and FII/DII data on Univest Screener.
Q: What are the key risks for Moldtek Technologies in Q4 FY26?
Key risks include: Global Macro Uncertainty, Discretionary Spend Weakness, AI Talent Cost Inflation. Investors should monitor management commentary on these risks in the Q4 earnings call.
Q: Is Moldtek Technologies a buy before Q4 results?
This article does not constitute investment advice. Whether to buy Moldtek Technologies before Q4 results depends on your risk appetite, existing portfolio exposure and entry price relative to fair value. Consult a SEBI-registered financial advisor before making any investment decision.
Q: How can I track Moldtek Technologies Q4 results live?
Track Moldtek Technologies Q4 FY26 results live on the Univest Screener, which provides real-time price updates, financial data and analyst research. Download the Univest iOS App or Android App for mobile alerts.
Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions. SEBI Registration: INH000012449.
Recent Article
VRL Logistics Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Vraj Iron and Steel Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Voltas Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Voltamp Transformers Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Vodafone Idea Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
